Breast Cancer
Natera Enrolls First Patients in HEROES Metastatic HER2+ Breast Cancer Trial
Natera's Signatera test and diagnostic imaging will be used to monitor patients for progression-free survival over the course of one year.
Personalis Q4 Revenues Fall 15 Percent as Full-Year Revenues Jump on Molecular Test Sales
The company's full-year 2024 revenues jumped 15 percent as dwindling contract revenues were buoyed by an uptick in molecular testing sales.
Syantra Nets New Funding for Breast Cancer Early Detection Test Validation
Funding from the Alberta Innovates Accelerating Innovations into Care Market Access program will allow the firm to assess the test in more high-risk patients.
MRC Holland Gets CE-IVDR Certification for Breast, Ovarian Cancer Syndrome Tests
The Amsterdam-based company recently received IVDR certification for other tests including one for phenylketonuria.
Breast Cancer Regulatory Networks Revealed in Single-Cell Study
Using single-cell epigenetic and transcriptomic analyses, researchers untangled regulatory features found within and across breast cancer subtypes.